Literature DB >> 30336989

Alzheimer Disease.

John E Morley1, Susan A Farr2, Andrew D Nguyen3.   

Abstract

Alzheimer disease is due to increased amyloid-β coupled with low progranulin. Several brain imaging techniques are helpful in the diagnosis. Drugs available for treating Alzheimer disease have limited clinical utility. Cognitive stimulation therapy is an effective therapy for persons with moderate Alzheimer disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid-β; Biomarkers; Cognitive stimulation therapy; Olive oil; Progranulin; SAMP8

Mesh：

Substances：

Year:  2018        PMID： 30336989     DOI： 10.1016/j.cger.2018.06.006

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


  7 in total

1.  Editorial: What is the Physiological Function of Amyloid-Beta Protein?

Authors:  J E Morley; S A Farr; A D Nguyen; F Xu
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Modeling Neurodegenerative Diseases Using In Vitro Compartmentalized Microfluidic Devices.

Authors:  Louise Miny; Benoît G C Maisonneuve; Isabelle Quadrio; Thibault Honegger
Journal:  Front Bioeng Biotechnol       Date:  2022-06-24

3.  Genetic association of BIN1 and GAB2 in Alzheimer's disease: A meta-analysis and systematic review.

Authors:  Xiaoyan Hao; Aijun Wang; Chong Li; Lufei Shao; Yi Li; Ping Yang
Journal:  Geriatr Gerontol Int       Date:  2020-12-16       Impact factor: 2.730

Review 4.  Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer's Disease Murine Models.

Authors:  Leticia Guadalupe Fragoso-Morales; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  Antioxidants (Basel)       Date:  2021-02-02

Review 5.  Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies.

Authors:  Piotr Londzin; Milena Zamora; Beata Kąkol; Aleksandra Taborek; Joanna Folwarczna
Journal:  Nutrients       Date:  2021-02-06       Impact factor: 5.717

6.  Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.

Authors:  Doaa Mousa; Nourhan Zayed; Inas A Yassine
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

7.  Treatment Combining Focused Ultrasound with Gastrodin Alleviates Memory Deficit and Neuropathology in an Alzheimer's Disease-Like Experimental Mouse Model.

Authors:  Kaixuan Luo; Yuhong Wang; Wen-Shiang Chen; Xiangjun Feng; Yehui Liao; Shaochun Chen; Yao Liu; Chengde Liao; Moxian Chen; Lijuan Ao
Journal:  Neural Plast       Date:  2022-01-13       Impact factor: 3.599
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.